Originally published July 26 2004
Pharmaceutical company owned by Johnson & Johnson distorted health risks to sell more prescription drugs
by Mike Adams, the Health Ranger, NaturalNews Editor
Here's another look at the admission of distortion by Janssen Pharmaceutica Products, a pharmaceutical company that has been misrepresenting the health risks of its pharmaceuticals to doctors and patients...
-
NEW YORK (Reuters) - Janssen Pharmaceutica Products, a unit of Johnson & Johnson, notified doctors that it minimized the risks of a popular drug for schizophrenia in promotional materials, according to the Associated Press.
- Janssen sent a two-page letter to health care workers this week to clarify the risks of the drug, the report said, citing Janssen spokeswoman Carol Goodrich.
- Goodrich did not immediately return a phone message left by Reuters.
- Last year the Food and Drug Administration told several makers of antipsychotic drugs to update their product labels.
- The agency determined that Janssen's promotional material minimized the risk of strokes, diabetes, and other potentially fatal complications, according to the AP.
- The agency also said that Janssen had made misleading claims that the medication was safer than similar drugs.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml